Analysis of CD8+ T-cells showed that, despite the disease outcome, an increased frequency of CD69+ and CD107a+, along with a decreased percentage of CD28+, CD27+, and CD45RO+ CD8+ T-cell subsets, were observed in both COVID-19 subgroups. This evidence concerns the gene CD8A and COVID-19.